Review

The 17th Annual Pharma Summit took place in London on February 10th. With eight out of the world’s top ten pharmaceutical companies attending, and over 200 delegates, this was one of best pharma events yet.

With an impressive line-up of speakers from top pharma companies including AstraZeneca, Astellas Pharma, Novo Nordisk, Nycomed, Pfizer, and sanofi-aventis. Keynote speeches came from John Lechleiter, CEO of Eli Lilly and David Redfern, Chief Strategy Officer, GlaxoSmithKline. Speakers gathered to discuss how the pharma industry needs to rebuild its image and position itself as a key industry in tomorrow's marketplace.

David Redfern speaks on pharma’s value proposition and how the industry must change

Videos of their speeches can be viewed here.

Twitter was again alive at the Pharma Summit with one tweeter commenting that: #pharmasummit was "the must-follow thread of the day". Notable Pharma companies tweeting included GSK, AstraZeneca, Astellas Pharma US, and Elmwood. Follow the summit @EC_PharmaSummit to view the tweets of the day.

Initial feedback has been very positive with Dr Nicolas Sireau, chairman, AKU Society commenting that:

"It was a fantastic day–very well organised, chaired and presented. The content was excellent and the networking opportunities were hugely valuable for us."